134 related articles for article (PubMed ID: 18759692)
1. Biomarker panel diagnosis of thyroid cancer: a critical review.
Griffith OL; Chiu CG; Gown AM; Jones SJ; Wiseman SM
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1399-413. PubMed ID: 18759692
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers.
Griffith OL; Melck A; Jones SJ; Wiseman SM
J Clin Oncol; 2006 Nov; 24(31):5043-51. PubMed ID: 17075124
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in the clinical application of thyroid cancer biomarkers.
Shibru D; Chung KW; Kebebew E
Curr Opin Oncol; 2008 Jan; 20(1):13-8. PubMed ID: 18043251
[TBL] [Abstract][Full Text] [Related]
4. Molecular phenotyping of thyroid tumors identifies a marker panel for differentiated thyroid cancer diagnosis.
Wiseman SM; Melck A; Masoudi H; Ghaidi F; Goldstein L; Gown A; Jones SJ; Griffith OL
Ann Surg Oncol; 2008 Oct; 15(10):2811-26. PubMed ID: 18612701
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for the diagnosis of thyroid cancer.
Sethi K; Sarkar S; Das S; Mohanty B; Mandal M
J Exp Ther Oncol; 2010; 8(4):341-52. PubMed ID: 21222366
[TBL] [Abstract][Full Text] [Related]
6. Circulating thyroid cancer markers.
Gupta M; Chia SY
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):383-8. PubMed ID: 17940468
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of CD56 immunohistochemistry in papillary carcinoma of the thyroid.
El Demellawy D; Nasr AL; Babay S; Alowami S
Pathol Res Pract; 2009; 205(5):303-9. PubMed ID: 19153015
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic usefulness of HBME1, galectin-3, CK19, and CITED1 and evaluation of their expression in encapsulated lesions with questionable features of papillary thyroid carcinoma.
Scognamiglio T; Hyjek E; Kao J; Chen YT
Am J Clin Pathol; 2006 Nov; 126(5):700-8. PubMed ID: 17050067
[TBL] [Abstract][Full Text] [Related]
9. Molecular markers in thyroid cancer diagnostics.
Kato MA; Fahey TJ
Surg Clin North Am; 2009 Oct; 89(5):1139-55. PubMed ID: 19836489
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in predicting thyroid malignancy.
Stang MT; Carty SE
Curr Opin Oncol; 2009 Jan; 21(1):11-7. PubMed ID: 19125013
[TBL] [Abstract][Full Text] [Related]
11. Application of immunohistochemistry in thyroid pathology.
Liu H; Lin F
Arch Pathol Lab Med; 2015 Jan; 139(1):67-82. PubMed ID: 25549145
[TBL] [Abstract][Full Text] [Related]
12. [Cellular tumor markers in thyroid cancer].
Kopczyńska E; Kwapisz J; Junik R; Tyrakowski T
Pol Merkur Lekarski; 2007 Apr; 22(130):295-9. PubMed ID: 17684930
[TBL] [Abstract][Full Text] [Related]
13. Peripheral thyrotropin receptor mRNA as a novel marker for differentiated thyroid cancer diagnosis and surveillance.
Barbosa GF; Milas M
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1415-24. PubMed ID: 18759693
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic potential of MIB-1 proliferation index in thyroid fine needle aspiration biopsy.
Sofiadis A; Tani E; Foukakis T; Kjellman P; Skoog L; Höög A; Wallin G; Zedenius J; Larsson C
Int J Oncol; 2009 Aug; 35(2):369-74. PubMed ID: 19578751
[TBL] [Abstract][Full Text] [Related]
15. ELISA microarray technology as a high-throughput system for cancer biomarker validation.
Zangar RC; Daly DS; White AM
Expert Rev Proteomics; 2006 Feb; 3(1):37-44. PubMed ID: 16445349
[TBL] [Abstract][Full Text] [Related]
16. An update on papillary microcarcinoma.
Grodski S; Delbridge L
Curr Opin Oncol; 2009 Jan; 21(1):1-4. PubMed ID: 19125011
[TBL] [Abstract][Full Text] [Related]
17. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
18. Medullary thyroid carcinoma and biomarkers: past, present and future.
van Veelen W; de Groot JW; Acton DS; Hofstra RM; Höppener JW; Links TP; Lips CJ
J Intern Med; 2009 Jul; 266(1):126-40. PubMed ID: 19522831
[TBL] [Abstract][Full Text] [Related]
19. Spindle epithelial tumor with thymus-like differentiation: a morphologic, immunohistochemical, and molecular genetic study of 11 cases.
Folpe AL; Lloyd RV; Bacchi CE; Rosai J
Am J Surg Pathol; 2009 Aug; 33(8):1179-86. PubMed ID: 19417583
[TBL] [Abstract][Full Text] [Related]
20. What are the current best immunohistochemical markers for the diagnosis of epithelioid mesothelioma? A review and update.
Ordóñez NG
Hum Pathol; 2007 Jan; 38(1):1-16. PubMed ID: 17056092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
